Answers are grounded in this paper and cite their sources.
The reaction of lithium phenyl(trimethylsilyl)methanide with phenyl(trimethylsilyl)methylzinc chloride‐tmeda in the presence of tmeda yields the addition product, a bis(tmeda)‐lithium dialkylchlorozincate. The elimination of lithium chloride leads to the formation of a tmeda adduct of bis[phenyl‐(trimethylsilyl)methyl]zinc. The metathesis reaction of phenyl(trimethylsilyl)methylzinc chloride‐tmeda with lithium tris(trimethylsilyl)silylamide allows the isolation of the corresponding heteroleptic tmeda complex of an alkylzinc amide. The metalation of phenyl(trimethylstannyl)methane with butyllithium yields the transmetalation product benzyllithium. From the metathesis reaction of this lithium base with anhydrous zinc(II) chloride in the presence of tmeda, the tmeda adduct of dibenzylzinc crystallizes. The molecular structures of (tmeda)LiCH(GeMe3)Ph, (tmeda)Zn(CH2Ph)2, (tmeda)Zn[CH(SiMe3)Ph]2, and (tmeda)Zn[CH(SiMe3)‐Ph[N(H)Si(SiMe3)3 are reported. Whereas lithium bonds in an η3‐fashion, the zinc atom forms a σ(ZnC) bond. The extremely wide ZnNSi angle in (tmeda)Zn[CH(SiMe3)‐Ph[N(H)Si(SiMe3)3 of 157° is remarkable.
No takes yet. Share an insight, caveat, or question.
Westerhausen et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: